ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2156

Differential Item Functioning of Inflammatory Back Pain Criteria in US Subpopulations

Mark Hwang1, Seokhun Kim2, Shervin Assassi3, Alexis Ogdie4, Michael Weisman5, John Reveille6 and Charles Green2, 1Department of Internal Medicine, Division of Rheumatology, John P. and Katherine G. McGovern School of Medicine, UTHealth Houston, Houston, TX, 2UTHealth Houston, Houston, 3UTHealth Houston Division of Rheumatology, Houston, TX, 4Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 5Stanford University, Los Angeles, CA, 6UTHealth Houston Division of Rheumatology, Houston

Meeting: ACR Convergence 2024

Keywords: Ankylosing spondylitis (AS), Back pain, Patient reported outcomes, Psychometrics, spondyloarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 18, 2024

Title: Patient Outcomes, Preferences, & Attitudes Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: IInflammatory back pain (IBP) has clinical features that distinguish it from other back pain etiologies.  While there are established IBP criteria, in different subpopulations criteria performance may differ.  This study investigates IBP criteria items in different age, gender and race groups from a nationally representative cohort.

Methods: Methods:  We studied the National Health and Nutrition Examination Survey (NHANES) 2009-2010 dataset, a US nationally representative data collection with demographic weighting.  In the dataset, the Arthritis Questionnaire (ARQ) included all questions from Calin, European Spondyloarthropathy Study Group (ESSG), and Berlin IBP criteria (8a and 7b question sets)(1). We applied Differential Item Functioning (DIF) Analysis based on Item response theory (IRT) for age (20-49 years vs. >50 years of age), gender (men vs. women) and race (white vs. non-white) groups on each IBP criterion.  With an anchor item selected from constrained baseline approach, chi-squared-based model comparison was performed to identify DIF for each item between the groups. Bonferroni correction was used adjust for multiple comparisons.

Results: There were 1511 patients with complete ARQ IBP questionnaires.  DIF analysis for age groups revealed DIF in at least 1 item for all IBP Criteria, suggesting systemic difference between younger and older patients’ responses. Berlin 8a showed one uniform DIF item, indicating that older individuals found it harder to answer ‘yes’ to the ‘improvement with exercise/no improvement with rest’ item but still had similar IBP discriminative ability.  Additionally, Berlin 7b’s ‘adult onset < 30 years old’ item displayed non-uniform DIF, indicating systematic bias across age groups. Non-uniform DIF/systematic bias for the items ‘adult onset < 40/< 45’ and ‘morning stiffness’ were observed in Calin and ESSG criteria. respectively. Other items showed no DIF for age groups. For Berlin 8a, a model with simultaneous constraints for all the identified DIF and non-DIFs (partial invariance model) was as good as the reference model with only anchor variable constrained. Further, the variance and mean of the latent IBP variable were equal between the age groups (Table 1)

In our race and gender analyses, DIF was only found in the Berlin 8a lower back pain item for gender groups (Tables 2 &3).  None of the other IBP criteria had DIF observed. For race groups, the partial invariance model was as good as the reference model for most of the criteria (Table 2). In contrast, for gender groups, the partial invariance model was not as good as the reference model for most of the criteria (Table 3).

Conclusion: These findings highlight the importance of considering demographic factors in the interpretation of IBP criteria, particularly in older patients and among different genders where systemic bias were observed.  Further research is warranted to explore the implications of these findings for accurate IBP detection, especially in diverse populations.

1.            Weisman MH, Witter JP, Reveille JD. The prevalence of inflammatory back pain: population-based estimates from the US National Health and Nutrition Examination Survey, 2009-10. Ann Rheum Dis. 2013;72(3):369-73.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: M. Hwang: Eli Lilly, 5, Janssen, 5, UCB Pharma, 2; S. Kim: None; S. Assassi: AstraZeneca, 2, aTyr, 2, 5, BMS, 2, Boehringer-Ingelheim, 2, 5, CSL Behring, 2, Janssen, 5, Merck/MSD, 2, TeneoFour, 2; A. Ogdie: AbbVie, 2, 5, Amgen, 2, 5, Bristol Myers Squibb, 2, Celgene, 2, CorEvitas, LLC, 2, Eli Lilly and Company, 2, Gilead, 2, GSK, 2, Janssen, 2, 5, Novartis, 2, 5, Pfizer, 2, 5, Takeda, 2, UCB Pharma, 2; M. Weisman: None; J. Reveille: None; C. Green: None.

To cite this abstract in AMA style:

Hwang M, Kim S, Assassi S, Ogdie A, Weisman M, Reveille J, Green C. Differential Item Functioning of Inflammatory Back Pain Criteria in US Subpopulations [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/differential-item-functioning-of-inflammatory-back-pain-criteria-in-us-subpopulations/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/differential-item-functioning-of-inflammatory-back-pain-criteria-in-us-subpopulations/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology